Acute Neurovascular Syndromes: Hurry Up, Please, It's Time

Stroke

Volumn 35, Issue 2, 2004, Pages 360-362

  Kennedy, J ^a   Buchan, A M ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

Advances in Stroke; Cerebral ischemia, transient; Diagnosis; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOLYTIC AGENT; GLIAL FIBRILLARY ACIDIC PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYELIN BASIC PROTEIN; NEURON SPECIFIC ENOLASE; PEPTIDE; PROTEIN S100B; TISSUE PLASMINOGEN ACTIVATOR; TROPONIN;

BLOOD BRAIN BARRIER; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; DRUG UTILIZATION; EARLY DIAGNOSIS; ELECTROCARDIOGRAM; FOLLOW UP; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PATIENT CARE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; ST SEGMENT ELEVATION; STROKE; TRANSIENT ISCHEMIC ATTACK;

ACUTE DISEASE; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CEREBROVASCULAR DISORDERS; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; EMERGENCY MEDICAL SERVICES; FIBRINOLYTIC AGENTS; HUMANS; ISCHEMIC ATTACK, TRANSIENT; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; SYNDROME; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0842332383     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000115260.19243.64     Document Type: Short Survey

References (33)

1. Eliot TS. Waste Land, pt. 2. 1922.
2. Chesterton GK. Scandal of Father Brown: Point of a Pin. 1935.
3. Bamford J, Sandercock P, Warlow C, Gray M. Why are stroke patients admitted to hospital? Br Med J (Clin Res Ed). 1986;292:1369-1372.
4. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue plasminogen activator for acute ischaemic stroke. N Engl J Med. 1995;333:1581-1587.
5. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, et al, for the PROACT Investigators. Intra-arterial prourokinase for acute ischemic stroke. JAMA. 1999;282: 2003-2011.
6. Lindley RI. Further randomized controlled trials of tissue plasminogen activator within 3 hours are required. Stroke. 2001;32:2708-2709.
7. Lyden PC. Further randomized controlled trials of tPA within 3 hours are required-not! Stroke. 2001;32:2710-2711.
8. Donnan GA, Davis SM. When is enough enough? Stroke. 2001;32: 2710-2711.
9. Marler JR, Tilley BC, Lu M, Brott TG, Lyden PD, Grotta JC, Broderick JP, Levine SR, Frankel MP, Horowitz SH, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA Stroke Study. Neurology. 2000;55:1649-1655.
10. Kennedy J, Ma C, Buchan AM. Organization of regional and local stroke resources, ways to expedite acute management of stroke. Curr Neurol Neurosci Rep. 2004;4:13-18.
11. Kennedy J, Buchan AM, Barnett HJM. Thrombolysis must be considered after stroke. BMJ. 2001;323:937. Letter.
12. Braunwald E. Unstable angina: a classification. Circulation 1989;80: 410-414.
13. Armstrong PW, Fu Y, Chang W-C, Topol EJ, Granger CB, Betriu A, Van de Werf F, Lee KL, Califf RM, for the GUSTO-IIb Investigators. Acute coronary syndromes in the GUSTO-IIb Trial: prognostic insights and impact of recurrent ischemia. Circulation. 1998;98:1860-1868.
14. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel B, Russell RO, Smith EE III, Weaver WD. ACC/AHA guidelines for the management of patients with acute myocardial infarction: 1999 update: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Available at www.acc.org. Accessed on December 1, 2003.
15. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: summary article: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation. 2002;106:1893-1900.
16. Whisnant JP, Matsumoto N, Elveback LR. Transient cerebral ischemic attacks in a community. Mayo Clin Proc. 1973;48:194-198.
17. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284: 2901-2906.
18. Lovett JK, Dennis MS, Sandercock PA, Bamford J, Warlow CP, Rothwell PM. Very early risk of stroke after a first transient ischemic attack. Stroke. 2003;34:e138-e40.
19. Eliasziw M, Kennedy J, Hill MD, Buchan AM, Barnett HJM, for the North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. Can Med Assoc J. In press.
20. NASCET Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-453.
21. Barnett HJM, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sackett DL, et al, for the NASCET Collaborators. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998;339: 1415-1425.
22. Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, Warlow CP, Barnett HJ, for the Carotid Endarterectomy Trialists' Collaboration. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet. 2003; 361:107-116.
23. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology. 2001;56:1015-1020.
24. Douglas VC, Johnston CM, Elkins J, Sidney S, Gress DR, Johnston SC. Head computed tomography findings predict short-term stroke risk after transient ischemic attack. Stroke. 2003;34:2894-2899.
25. Kang DW, Latour LL, Chalela JA, Dambrosia J, Warach S. Early ischemic lesion recurrence within a week after acute ischemic stroke. Ann Neurol. 2003;54:66-74.
26. Lamers KJ, Vos P, Verbeek MM, Rosmalen F, van Geel WJ, van Engelen BG. Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients. Brain Res Bull. 2003;61: 261-264.
27. Arenillas JF, Alvarez-Sabin J, Molina CA, Chacon P, Montaner J, Rovira A, Ibarra B, Quintana M. C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke. 2003;34:2463-2468.
28. International Stroke Trialists Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients. Lancet. 1997;349:1569-1581.
29. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Lancet. 1997;349:1641-1649.
30. Chen ZM, Sandercock P, Pan HC, Counsell C, Collins R, Liu LS, Xie JX, Warlow C, Peto R. Indications for early aspirin use in acute ischemic stroke. Stroke. 2000;31:1240-1249.
31. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
32. Schwartz GG, Olsen AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomised controlled trial. JAMA. 2001;285: 1711-1718.
33. Kennedy J, Eliasziw M, Hill MD, Buchan AM. The Fast Assessment of Stroke and Transient ischemic attack to prevent Early Recurrence (FASTER) Trial. Semin Cerebrovasc Dis Stroke. 2003;3/1:25-30.